RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -1.6% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 112 | +7 | 44.38M | $4.90B | +14 | −8 |
| Q1 2026 | 109 | +6 | 41.83M | $3.64B | +11 | −6 |
| Q4 2025 | 102 | 0 | 43.14M | $4.62B | +3 | −2 |
| Q3 2025 | 20 | +1 | 28.88M | $2.92B | +2 | −2 |
| Q2 2025 | 17 | 0 | 22.96M | $1.45B | +1 | −1 |
| Q1 2025 | 14 | +2 | 11.52M | $610.22M | +2 | — |
| Q4 2024 | 12 | 0 | 11.40M | $638.39M | — | — |
| Q3 2024 | 11 | +3 | 9.71M | $508.75M | +3 | — |
| Q2 2024 | 8 | — | 9.56M | $392.54M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 6.27M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | PRIMECAP Management ✦ | 4.88M | -15.7% | $308.24M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 3.59M | — | $226.80M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | Fidelity (FMR) ✦ | 1.95M | — | $123.44M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 5 | State Street Global Advisors ✦ (pasif) | 1.91M | -3.2% | $120.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.34M | +11.9% | $84.76M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (pasif) | 1.31M | +1.9% | $82.87M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 376.24K | -29.7% | $23.77M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Adage Capital Partners ✦ | 341.00K | Baru | $21.55M | 0.0% | New | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 314.89K | +2131.4% | $19.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Norges Bank ✦ (pasif) | 207.39K | -7.2% | $13.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Millennium Management ✦ | 198.11K | -8.9% | $12.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 170.83K | +167.6% | $10.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 49.04K | +24.6% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 15 | D. E. Shaw & Co. ✦ | 24.28K | -71.0% | $1.53M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 16 | Wellington Management ✦ | 22.43K | -4.8% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 17 | Gotham Asset Management ✦ | 4.85K | +2.1% | $306,535 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Adage Capital Partners | $21.55M | 0.0% |
Telah keluar
| Citadel Advisors | $3.71M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 284 pemegang, 72.02M saham, $6.12B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 1.82K lbr · $189,965
Officer, Director · 8.70K lbr · $899,634
Officer, Director · 30.75K lbr · $3.15M
Officer, Director · 6.44K lbr · $655,145
Officer, Director · 2.30K lbr · $241,937
Officer · 11.51K lbr · $1.21M
Officer · 23.07K lbr · $2.41M
Officer · 28.19K lbr · $2.99M
Officer · 2.01K lbr · $233,031
Officer · 1.56K lbr · $182,170
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi